Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of the Effects of High-Dose N-Acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF) (IFIGENIA)

This study has been completed.
Sponsor:
Information provided by:
Zambon SpA
ClinicalTrials.gov Identifier:
NCT00639496
First received: March 13, 2008
Last updated: March 19, 2008
Last verified: March 2008